However, people in the healthy control group exhibited higher frequencies of DN1 B cells and lower frequencies of DN3 B cells compared with patients with IBD treated with anti-TNF (Supplemental Figure 5D). This evidence concerns the gene TNF and inflammatory bowel disease.